JUN and breast cancer: Indeed, AP-1 over-expression was correlated with ATRA resistance in breast tumor cell lines, and some ER- cell breast cancer lines (BT20, Hs578T, MDA-MB-231, MDA-MB-468) showed this over-expression [219].